{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:07:24Z","timestamp":1788883644508,"version":"build-2803163510"},"reference-count":65,"publisher":"Mark Allen Group","issue":"Sup9a","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Wound Care"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Hard-to-heal wounds remain a major healthcare challenge due to persistent inflammation, extracellular matrix (ECM) degradation, impaired angiogenesis and failure to progress through normal healing pathways. Standard wound care alone often fails to achieve timely wound closure, necessitating biologically active therapies that restore the wound microenvironment. High-purity type I collagen (HPTC) (Helicoll, EnColl Corp, Fremont, CA, US) is a uncrosslinked skin substitute designed to function as a biologically active ECM scaffold that supports tissue regeneration rather than serving solely as a passive wound covering.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive literature review was conducted of the clinical, mechanistic, technical and economic evidence supporting HPTC. The evidence base included six randomised controlled trials (RCTs), pooled analyses, comparative studies, observational investigations and health-economic evaluations spanning diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure ulcers (PUs), burns, donor sites, surgical wounds and complex wounds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Across hard-to-heal wound studies, HPTC consistently demonstrated improved healing outcomes compared with active comparators and standard therapies. DFU studies demonstrated complete closure rates up to 83.3% compared with approximately 51.7% in comparator groups, with \u226550% wound reduction observed in 85\u201388% of patients at 4 weeks. VLU studies demonstrated closure rates approaching 70% compared with 43.3% for comparators, while PU studies demonstrated closure rates of approximately 75%. Mechanistically, preserved native collagen structure enabled physiological cell adhesion, growth factor binding, protease modulation, angiogenesis, fibroblast recruitment and ECM restoration. No significant safety concerns or serious adverse events attributable to HPTC were reported. Economic analyses further demonstrated favourable cost-effectiveness, reduced application frequency and lower overall treatment costs relative to competing advanced wound therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>HPTC is supported by multiple clinical studies that demonstrate efficacy across multiple hard-to-heal and acute wound types. Preservation of native collagen architecture, absence of chemical crosslinking, physiologically relevant scaffold structure and favourable safety and economic profiles collectively support its role as an evidencebased advanced wound therapy. Evidence supports HPTC's clinical utility and integration into routine wound care practice for management of complex wounds. These findings validate HPTC's medical necessity and economic value, underscoring its status as an advanced wound therapy with emerging supportive evidence rather than an experimental or investigational intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statement of interest:<\/jats:title>\n                    <jats:p>Funding for the preparation of this manuscript was provided by Encoll Corp (Fremont, CA, US), manufacturer of HPTC. The author reports receiving support related to development of this review. The sponsor reviewed the manuscript for scientific accuracy but did not control the final interpretation or conclusions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.12968\/jowc.2026.35.sup9a.s4","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:45:42Z","timestamp":1788875142000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical utility and medical necessity of high-purity type I collagen in hard-to-heal wound management: a review of evidence"],"prefix":"10.12968","volume":"35","author":[{"given":"Windy","family":"Cole","sequence":"first","affiliation":[{"name":"Director of Wound Care Research, Kent State University College of Podiatric Medicine, Independence, OH, US"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5130","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15102"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.70155"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.10578"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001192"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","unstructured":"Oyebode OA Jere SW Houreld NN. Current therapeutic modalities for the management of chronic diabetic wounds of the foot. Chattopadhyay M ed. J Diabetes Res. 2023:1\u201310. 10.1155\/2023\/1359537","DOI":"10.1155\/2023\/1359537"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","unstructured":"Xu F Zhang C Graves DT. Abnormal cell responses and role of TNF-\u03b1 in impaired diabetic wound healing. BioMed Research International. 2013:1\u20139. 10.1155\/2013\/754802","DOI":"10.1155\/2013\/754802"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14020214"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12492"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3182818a3d"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2702.2003.00662.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/jep.12983"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","unstructured":"Armstrong DG Hanft J Surprenant M et al. Comparing the efficacy of a unique advanced bioengineered type-I collagen-based skin substitute versus an amnion graft with standard of care in the treatment of non-healing diabetic foot ulcers: a randomized clinical trial. Cureus. 2025. 10.7759\/cureus.78021","DOI":"10.7759\/cureus.78021"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","unstructured":"Narayan N Gowda S Shivannaiah C. A randomized controlled clinical trial comparing the use of high purity type-I collagen-based skin substitute vs. dehydrated human amnion\/chorion membrane in the treatment of diabetic foot ulcers. Cureus J Med Science. 2024. 10.7759\/cureus.75182","DOI":"10.7759\/cureus.75182"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","unstructured":"Narayan N Shivaiah R Kumar V et al. Comparative efficacy of high purity type I collagen-based skin substitute and dehydrated human amnion\/chorion membrane in diabetic foot ulcers: a multicentre randomized controlled trial. Cureus. 2025. 10.7759\/cureus.94952","DOI":"10.7759\/cureus.94952"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","unstructured":"Narayan N Shivannaiah C Gowda S. Evaluating the efficacy of high-purity type I collagen-based skin substitute versus dehydrated human amnion\/chorion membrane in the treatment of venous leg ulcers: a randomized controlled clinical trial. Cureus J Med Science. 2025. 10.7759\/cureus.89031","DOI":"10.7759\/cureus.89031"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.90956"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s44174-025-00275-8"},{"key":"e_1_3_2_18_2","unstructured":"Gunasekaran S Rajendran M Swaminathan T Dhawan S. Modified collagen for burns enhances healing rate possibly by cell signalling (presentation at the American Society for Dermatological Surgery Annual Meeting New Orleans). 2003. https:\/\/helicoll.com\/wp-content\/uploads\/2024\/03\/Modified_Collagen_for_Burns_Enhances_Healing_Rate_Possibly_by_Cell_Signalling.pdf (accessed 20 August 2026)"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12262-013-0850-3"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12663-018-1172-6"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.5530\/ami.2016.1.30"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2025.0254"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.1999.08230.x"},{"key":"e_1_3_2_24_2","unstructured":"Ankur P. Cost effectiveness of commonly used skin substitutes in the management of diabetic foot ulcers (poster presented at the Symposium on Advanced Wound Care). 2020. https:\/\/www.hmpgloballearningnetwork.com\/site\/woundcare\/poster\/cost-effectiveness-commonly-used-skin-substitutes-management-diabetic-foot-ulcers (accessed 20 August 2026)"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.34257\/GJMRK256986"},{"key":"e_1_3_2_26_2","unstructured":"Gunasekaran S Dhanraj P Kwolek M. Bioactive collagen matrix for the treatment of burns donor sites and ulcers (presentation at World Biomaterials Congress Amsterdam EnColl data on file). 2008"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","unstructured":"Narayan N Raghupathi D Ramamurthy V et al. A comparative analysis in the treatment of full-thickness wounds: negativepressure wound therapy (NPWT) combined with high-purity type I collagen-based skin substitute versus NPWT alone. Cureus. 2025. 10.7759\/cureus.96977","DOI":"10.7759\/cureus.96977"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6093974"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120096"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15052"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a004978"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201801651"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2016.11.059"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2019.09.046"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-151282"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-475X.2008.00410.x"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2003.83.3.835"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0142-9612(96)81413-X"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(98)00242-7"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(99)00069-1"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120109"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/bit.26182"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1506433"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8191.1988.tb00446.x"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1444986"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10616-015-9895-4"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(03)00630-6"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2009.09.063"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","unstructured":"Xing F Li L Zhou C et al. Regulation and directing stem cell fate by tissue engineering functional microenvironments: scaffold physical and chemical cues. Stem Cells International. 2019:1\u201316. 10.1155\/2019\/2180925","DOI":"10.1155\/2019\/2180925"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10856-018-6175-9"},{"key":"e_1_3_2_51_2","unstructured":"Gunasekaran S. Collagen structure affected by production method impacts clinical outcome (poster presented at the Symposium on Advanced Wound Care US). 2020. https:\/\/helicoll.com\/wp-content\/uploads\/2024\/03\/SAWC_Fall_2020-02.jpg (accessed 20 August 2026)"},{"issue":"17","key":"e_1_3_2_52_2","first-page":"3857","article-title":"Injectable collagen as a biomaterial: structural and sterilization considerations","volume":"25","author":"Rosenblatt J","year":"2004","unstructured":"Rosenblatt J, Devereux B, Wallace DG. Injectable collagen as a biomaterial: structural and sterilization considerations. Biomaterials. 2004;25(17):3857\u20133863","journal-title":"Biomaterials"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(01)00412-4"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2016.10.030"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e318254b1ea"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/SAP.0000000000002096"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.12434"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-8-201310150-00006"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S012"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1615243"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2018.27.3.136"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2018.27.2.68"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.70782"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666171205170339"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/XCS.0000000000000884"}],"container-title":["Journal of Wound Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/pdf\/10.12968\/jowc.2026.35.sup9a.S4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:23:33Z","timestamp":1788881013000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/10.12968\/jowc.2026.35.sup9a.S4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":65,"journal-issue":{"issue":"Sup9a","published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["10.12968\/jowc.2026.35.sup9a.S4"],"URL":"https:\/\/doi.org\/10.12968\/jowc.2026.35.sup9a.s4","relation":{},"ISSN":["0969-0700","2052-2916"],"issn-type":[{"value":"0969-0700","type":"print"},{"value":"2052-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}